Instil Bio, Inc. Operating Income Loss

• Instil Bio, Inc. showed a decrease of -6.9% in Operating Income Loss from 2024 to 2025.
• This data is from Instil Bio, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
• XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 6 years of available data (2020 to 2025), Instil Bio, Inc.'s Operating Income Loss has declined by 133.6%.
• Historical annual values: Fiscal year 2025: -$78.58 million | Fiscal year 2024: -$73.54 million | Fiscal year 2023: -$159.17 million | Fiscal year 2022: -$226.46 million | Fiscal year 2021: -$155.56 million | Fiscal year 2020: -$33.64 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026